ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

TLRY vs RGC // RSI-14 & 200D SMA MOMENTUM

Tilray Brands Inc. (NASDAQ) VS. Regencell Bioscience Holdings Limited (NASDAQ) • 15-METRIC TALLY: TLRY 1 — RGC 3
▲ RSI-14 & 200D SMA MOMENTUM LEADER: RGC
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TLRY VS. RGC) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC TLRY RGC SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 28.40% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -3.90% — — TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -17.72% -0.10% -17.62 RGC /fcf-yield <GO>
Operating Margin -6.90% — — TIE /operating-margins <GO>
Net Profit Margin -13.30% — — TIE /net-margins <GO>
Revenue Growth (YoY) 11.50% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 2/9 +3.00 TLRY /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum ACTIVE 25.8 44.1 -18.30 RGC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $390.2M $3.40B -$3.01B RGC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR TLRY REV RGC REV TLRY GROSS % RGC GROSS % TLRY FCF RGC FCF
FY 2025 $915.5M $0 28.4% — -$69.1M -$3.3M
FY 2024 $821.3M $0 29.3% — -$94.6M -$4.0M
FY 2023 $788.9M $0 — — -$30.9M -$5.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TLRY // BETA —
RGC // BETA —